Biography and Research Information
OverviewAI-generated summary
Rebekah N. Thompson's research focuses on microbial infections and the development of resistance to antimicrobial agents. Her work has investigated treatment-emergent resistance mechanisms in carbapenem-resistant *Acinetobacter baumannii*, specifically examining the role of insertion sequences in siderophore receptor genes. Thompson has also explored therapeutic strategies for complex infections, including the use of combination antibiotic therapy for multidrug-resistant Gram-negative bacteria. She has co-authored publications with researchers at the University of Arkansas for Medical Sciences, including Ryan K. Dare, Jacob M. Keck, Michael Saccente, and Keyur S. Vyas. Thompson's publication record includes two papers, with her most recent work published in 2025, and her scholarship metrics include an h-index of 1 with 19 total citations.
Metrics
- h-index: 1
- Publications: 2
- Citations: 21
Selected Publications
-
Use of Aztreonam–Avibactam with Rapid Eravacycline Step-Down Therapy for a Tibial Septic Non-Union by NDM-Producing Enterobacter cloacae (2025)
-
Treatment-emergent cefiderocol resistance in carbapenem-resistant <i>Acinetobacter baumannii</i> is associated with insertion sequence IS <i>Aba36</i> in the siderophore receptor <i>pirA</i> (2024)
Collaboration Network
Top Collaborators
Jacob M. Keck
University of Arkansas for Medical Sciences
2 shared publications
In database
- Treatment-emergent cefiderocol resistance in carbapenem-resistant <i>Acinetobacter baumannii</i> is associated with insertion sequence IS <i>Aba36</i> in the siderophore receptor <i>pirA</i>
- Use of Aztreonam–Avibactam with Rapid Eravacycline Step-Down Therapy for a Tibial Septic Non-Union by NDM-Producing Enterobacter cloacae
Ryan K Dare
University of Arkansas for Medical Sciences
2 shared publications
In database
- Treatment-emergent cefiderocol resistance in carbapenem-resistant <i>Acinetobacter baumannii</i> is associated with insertion sequence IS <i>Aba36</i> in the siderophore receptor <i>pirA</i>
- Use of Aztreonam–Avibactam with Rapid Eravacycline Step-Down Therapy for a Tibial Septic Non-Union by NDM-Producing Enterobacter cloacae
En Huang
University of Arkansas for Medical Sciences (US)
1 shared publication
- Treatment-emergent cefiderocol resistance in carbapenem-resistant <i>Acinetobacter baumannii</i> is associated with insertion sequence IS <i>Aba36</i> in the siderophore receptor <i>pirA</i>
Sun Hee Moon
University of Arkansas for Medical Sciences (US)
1 shared publication
- Treatment-emergent cefiderocol resistance in carbapenem-resistant <i>Acinetobacter baumannii</i> is associated with insertion sequence IS <i>Aba36</i> in the siderophore receptor <i>pirA</i>
Michael S. Lowry
University of Arkansas for Medical Sciences (US)
1 shared publication
- Treatment-emergent cefiderocol resistance in carbapenem-resistant <i>Acinetobacter baumannii</i> is associated with insertion sequence IS <i>Aba36</i> in the siderophore receptor <i>pirA</i>
Joe Melero
University of Arkansas for Medical Sciences
1 shared publication
In database
- Treatment-emergent cefiderocol resistance in carbapenem-resistant <i>Acinetobacter baumannii</i> is associated with insertion sequence IS <i>Aba36</i> in the siderophore receptor <i>pirA</i>
Se‐Ran Jun
University of Arkansas for Medical Sciences
1 shared publication
In database
- Treatment-emergent cefiderocol resistance in carbapenem-resistant <i>Acinetobacter baumannii</i> is associated with insertion sequence IS <i>Aba36</i> in the siderophore receptor <i>pirA</i>
Eric Rosenbaum
University of Arkansas for Medical Sciences (US)
1 shared publication
- Treatment-emergent cefiderocol resistance in carbapenem-resistant <i>Acinetobacter baumannii</i> is associated with insertion sequence IS <i>Aba36</i> in the siderophore receptor <i>pirA</i>
Michael Saccente
University of Arkansas Medical Center
1 shared publication
In database
- Use of Aztreonam–Avibactam with Rapid Eravacycline Step-Down Therapy for a Tibial Septic Non-Union by NDM-Producing Enterobacter cloacae
Keyur S. Vyas
University of Arkansas for Medical Sciences
1 shared publication
In database
- Use of Aztreonam–Avibactam with Rapid Eravacycline Step-Down Therapy for a Tibial Septic Non-Union by NDM-Producing Enterobacter cloacae
Similar Researchers
Based on overlapping research topics
John Block
University of Arkansas for Medical Sciences
Antibiotic Resistance in Bacteria
Microbial infections and disease research
Drug Transport and Resistance Mechanisms
En Huang
University of Arkansas for Medical Sciences
Antibiotic Resistance in Bacteria
Microbial infections and disease research
Drug Transport and Resistance Mechanisms
Tucker Blackledge
University of Arkansas for Medical Sciences
Antibiotic Resistance in Bacteria
Microbial infections and disease research
Drug Transport and Resistance Mechanisms
Thomas Cunningham
University of Arkansas for Medical Sciences
Antibiotic Resistance in Bacteria
Microbial infections and disease research
Drug Transport and Resistance Mechanisms
Michael S. Lowry
University of Arkansas for Medical Sciences
Antibiotic Resistance in Bacteria
Microbial infections and disease research
Bacterial Genetics and Biotechnology
Sree Vamsee Chintapalli
University of Arkansas for Medical Sciences
Antibiotic Resistance in Bacteria
Microbial infections and disease research
Bacterial Genetics and Biotechnology